Pan-Cancer 1 (EGFR, KRAS, NRAS, BRAF, IDH1) Crystal Digital PCR® Assay

Oncology

Assay-specific Crystal Flex Probes and primers for the detection of EGFR, KRAS, NRAS, BRAF, and IDH1 mutations and its Positive Control.

For Research Use Only. Not for use in diagnostic procedures.

Wet-lab tested

Compatibility

Channels

Blue
Teal
Green
Yellow
Red
Infra-Red

Required Reagents

Gene

Product Details

The Pan-Cancer1 (EGFR, KRAS, NRAS, BRAF, IDH1) Crystal Digital PCR® Assay is a 10X assay designed to detect and quantify mutations in multiple genes using the Ruby Chip. These genes play major roles in regulating cell signaling pathways, and their mutations drive tumor development. Numerous targeted therapies are available, in which mutation identification and monitoring is the key to selecting the right therapeutic approach.

This assay is available in 200 and 1000 reaction formats.

Features & Benefits

Ready-to-use assay reagents to detect multiple targets in a single reaction

Crystal Flex Probe detection chemistry for flexible assay configuration

Same set of Crystal Universal Reporters to detect any target in different assays

High multiplexing with low price per point

Targets

EGFR deletion exon 19/L858R

KRAS G12C/G12D

NRAS Q61R

BRAF V600E

IDH1 R132H

Assays & kits

Ready-to-use assays & kits

Explore our catalogue of assays and kits and take a leap into the world of multiplexing. Crystal Digital PCR® assays and kits allow for the detection of multiple targets of interests within one single Ruby Chip chamber.

Custom assay design services

Rapid high-plex assay customization

Stilla offers the fastest assay design service in the market for multiplexed digital PCR assays. Stilla exploits its proprietary Crystal Flex Probe PCR chemistry to offer customized assays in record time, at competitive prices.